Chee Kong Choo

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Singapore, Singapore
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Chee Kong Choo
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Chee Kong Choo

Form 4 holding Director, 10%+ Owner

CytoMed Therapeutics Ltd

Security class
Ordinary Shares, no par value per share
Shares / value
410,515
Estimated value
Report date
31 Mar 2023
Price
Ownership
Indirect

Insider Reports Filed by Chee Kong Choo

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .